Evolus expects sustained adjusted EBITDA profitability beginning in 2026PUBT·Nov 4, 2026 at 10:42 PMEOLS+8.96%
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLSprnewswire·Oct 29, 2026 at 02:26 PMEOLS+8.96%
Evolus Participates in Stifel and Jefferies Healthcare ConferencesPUBT·Oct 28, 2026 at 12:30 PMEOLS+8.96%
Evolus to Report Third Quarter Financial Results on November 4, 2026Unusual Whales·Oct 21, 2026 at 12:35 PMEOLS+8.96%
Evolus signs option deal with private partner for sustained-release injectable hair restoration programPUBT·Oct 14, 2026 at 12:32 PMEOLS+8.96%
FDA dings Evolus for blurred lines between Botox rival, lipstickFiercepharma·Oct 5, 2026 at 10:28 AMEOLS+8.96%
Evolus Warned Over Misbranding in Social Media Promo for Frown Lines Drugbenzinga_article·Oct 2, 2026 at 05:47 PMEOLS+8.96%
